BB Biotech Balance Sheet Health
Financial Health criteria checks 4/6
BB Biotech has a total shareholder equity of CHF2.3B and total debt of CHF304.9M, which brings its debt-to-equity ratio to 13.1%. Its total assets and total liabilities are CHF2.6B and CHF313.9M respectively.
Key information
13.1%
Debt to equity ratio
CHF304.90m
Debt
Interest coverage ratio | n/a |
Cash | CHF2.64b |
Equity | CHF2.32b |
Total liabilities | CHF313.94m |
Total assets | CHF2.64b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: BBAG.F's short term assets (CHF2.6B) exceed its short term liabilities (CHF313.9M).
Long Term Liabilities: BBAG.F has no long term liabilities.
Debt to Equity History and Analysis
Debt Level: BBAG.F has more cash than its total debt.
Reducing Debt: BBAG.F's debt to equity ratio has increased from 6.4% to 13.1% over the past 5 years.
Debt Coverage: BBAG.F's debt is well covered by operating cash flow (71.6%).
Interest Coverage: Insufficient data to determine if BBAG.F's interest payments on its debt are well covered by EBIT.